Forge Biologics News and Activities

Forge Biologics is owned by Ajinomoto.

Ajinomoto is one of the...

• Forbes Global 2000 (#1274);
• Nikkei 225;
• TOB Iconic 10,000;
• Topix.

Ajinomoto is a company listed under the stock ticker 2802 (JP).

Ajinomoto has a direct presence in 3 countries.

Ajinomoto has 6 subsidiaries including Ajinomoto Bio-Pharma Japan, Ajinomoto BioPharma and Ajinomoto BioPharma Europe.

They are in:

• Pharmaceuticals43%
• Food29%
• Other29%

View the org chart displaying its 20 main executives

Most searched biographies at Forge Biologics

• John Maslowski, President, Chief Executive Officer and Director
• Yasuyuki Otake, Chairman of the Board
• David Dismuke, Chief Technical Officer

Popular executive movements at Ajinomoto

• Hiroshi Kaho, who was President and Chief Executive Officer of Ajinomoto Foods North America, is promoted to Executive Officer and Executive Vice President, Chief Human Resources Officer  (posted on May 15 2026).

Create your alert
to follow the executive moves at Forge Biologics.

Ajinomoto has 2,406 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
• NewLimit has just announced a $435 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by Forge Biologics

• Epicrispr Biotechnologies and Forge Biologics Announce AAV Development and Manufacturing Pact
• Companies partner to speed production of 1-time FSHD treatment
• Epicrispr Biotechnologies Partners with Forge Biologics for EPI-321 Manufacturing - PharmaSource
• Forge Biologics Among Select Global CDMOs to Earn My Green Lab® Certification Across All Laboratories and cGMP Suites
• Progeria Research Foundation, Forge Biologics Enter Gene Therapy Mfg. Pact
• Forge Biologics Agrees to Develop and Manufacture Gene Therapy for Progeria
• Ascidian Therapeutics, Forge Biologics Partner to Manufacture Stargardt RNA-Editing Therapy
• Ascidian Therapeutics and Forge Biologics Announce Manufacturing Partnership to Advance RNA Editing Therapy for Stargardt Disease
• Ascidian Therapeutics, Forge Biologics Partner to Advance Stargardt Treatment
• Ascidian Therapeutics Partners with Forge Biologics to Manufacture ACDN-01 Gene Therapy - PharmaSource
• View more press releases Close

Social media about Forge Biologics

• Forge Biologics on Wikipedia, Google News & Yahoo Finance
• Forge Biologics on LinkedIn, X (Twitter) & YouTube